Pharmaceutical - Quintiles, Regulation

Filter

Current filters:

QuintilesRegulation

Popular Filters

Importance of early planning in pharma market access in Europe

15-11-2012

With payers playing an increasingly critical role in physician prescribing practices across Europe, regulatory…

EuropeMarkets & MarketingPharmaceuticalQuintilesRegulation

Quintiles to expand clinical development capabilities in Russia

26-02-2012

Biopharmaceutical services company Quintiles is moving further into emerging markets, last week signing…

EuropePharmaceuticalQuintilesRegulationResearchRVC Biofund

Quintiles expands in MENA pharma markets

16-02-2012

Biopharmaceutical services company Quintiles is extending its global footprint to provide commercial…

Dayarn PharmaMarkets & MarketingPharmaceuticalQuintilesRegulationRest of the World

Drug approval and launch for Novartis in China, where Quintiles expands

18-01-2012

Swiss drug major Novartis (NOVN: VX) says it has received regulatory approval in China from the State…

Asia-PacificDiabetesGalvusLucentisMarkets & MarketingNovartisOphthalmicsPharmaceuticalQuintilesRegulationResearch

Back to top